1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with 15(s)-15-methylprostaglandin e1 in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (15(s)-15-methylprostaglandin e1) | Trials (15(s)-15-methylprostaglandin e1) | Recent Studies (post-2010) (15(s)-15-methylprostaglandin e1) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 24 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rampart, M; Williams, TJ | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 15(s)-15-methylprostaglandin e1
| Article | Year |
|---|---|
Polymorphonuclear leukocyte-dependent plasma leakage in the rabbit skin is enhanced or inhibited by prostacyclin, depending on the route of administration.
Topics: Alprostadil; Animals; Bradykinin; Complement C5; Complement C5a, des-Arginine; Drug Synergism; Edema; Epoprostenol; Infusions, Parenteral; Injections, Intradermal; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Plasma Volume; Platelet Activating Factor; Rabbits; Skin Diseases | 1986 |